Most current drug therapy development is based on research of genes that were discovered in 1987 and are responsible for early onset Alzheimer's disease, which accounts for only 5-10% of the total Alzheimer's population.
 
A+ | A- | Reset
John C. Mazziotta, M.D., Ph.D. Print
John C. Mazziotta, M.D., Ph.DUCLA School of Medicine
Chair, Department of Neurology; Directors of the UCLA Brain Mapping Center; Associate Director of the Neuropsychiatric Institute; Frances Stark Chair of Neurology; Pierson-Lovelace Investigator; Professor of Neurology, Radiological Sciences and Pharmacology, Ahmanson-Lovelace Brain Mapping Center.

Dr. Mazziotta is a pioneer and leader in applying imaging technology to our understanding of the functions of the brain. His research, teaching, writing and presentations have furthered developments in brain mapping through the use of such technologies as Position Emission Tomography. He is currently leading the International Consortium of Brain Mapping.
 
< Prev   Next >
[ Back ]